Immunological interactions between human eosinophils and cardiac mast cells

Chemical Immunology

Volumn 76, Issue , 2000, Pages 118-133

  Marone, Gianni ^a,b   Patella, Vincenzo ^a   De Crescenzo, Gennaro ^a   Granata, Francescopaolo ^a   Calabrese, Cecilia ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; EOSINOPHIL CATIONIC PROTEIN; HISTAMINE; ICOSANOID; MAJOR BASIC PROTEIN; NEUROTOXIN; PEROXIDASE; TRYPTASE;

ANAPHYLAXIS; BLOOD VESSEL PERMEABILITY; CARDIOVASCULAR DISEASE; CELL INTERACTION; CHURG STRAUSS SYNDROME; ENDOCARDIUM; ENZYME RELEASE; EOSINOPHIL; EXTRACELLULAR CALCIUM; HEART MUSCLE FIBROSIS; HISTAMINE RELEASE; HUMAN; HYPEREOSINOPHILIA; ICOSANOID METABOLISM; MAST CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; THROMBOSIS;

EID: 0034062090     PISSN: 10150145     EISSN: None     Source Type: Journal    
DOI: 10.1159/000058784     Document Type: Review

References (23)

1. Fauci AS, Harley JB, Roberts WC, Ferrans VJ, Gralnick HR, Bjornson BH: NIH Conference: The idiopathic hypereosinophilic syndrome: Clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med 1982;97:78-92.
2. Weller PF, Bubley GJ: The idiopathic hypereosinophilic syndrome. Blood 1994;83:2759-2779.
3. Rothenberg ME: Eosinophilia. N Engl J Med 1998;338:1592-1600.
4. Moqbel R, Ying S, Barkans J, Newman TM, Kimmitt P, Wakelin M, Taborda-Barata L, Meng Q, Corrigan J, Durham SR, Kay AB: Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product. J Immunol 1995;155:4939-4947.
5. Egesten A, Calafat J, Knol EF, Janssen H, Walz TM: Subcellular localization of transforming growth factor-α in human eosinophil granulocytes. Blood 1996;87:3910-3918.
6. Nakajima H, Gleich GJ, Kita H: Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils. J Immunol 1996;156:4859-4866.
7. Okada S, Hagan JB, Kato M, Bankers-Fulbright JL, Hunt LW, Gleich GJ, Kita H: Lidocaine and its analogues inhibit IL-5-mediated survival and activation of human eosinophils. J Immunol 1998; 160: 4010-4017.
8. Grewe M, Czech W, Morita A, Werfel T, Klammer M, Kapp A, Ruzicka T, Scöpf E, Krutmann J: Human eosinophils produce biologically active IL-12: Implications for control of T cell responses. J Immunol 1998;161:415-420.
9. Yamamoto H, Sedgwick JB, Busse WW: Differential regulation of eosinophil adhesion and transmigration by pulmonary microvascular endothelial cells. J Immunol 1998;161:971-977.
10. Leiferman KM: Hypereosinophilic syndrome. Semin Dermatol 1995;14:122-128.
11. Hardy WR, Anderson RE: The hypereosinophilic syndromes. Ann Intern Med 1968;68:1220-1229.
12. Chusid MJ, Dale DC, West BC, Wolff SM: The hypereosinophilic syndrome: Analysis of fourteen cases with review of the literature. Medicine (Baltimore) 1975;54:1-27.
13. Solley GO, Maldonato JE, Gleich GJ, Giuliani ER, Hoagland HC, Pierre RV, Brown AL Jr: Endomyocardiopathy with eosinophilia. Mayo Clin Proc 1976;51:697-708.
14. de Mello DE, Liapis H, Jureidini S, Nouri S, Kephart GM, Gleich GJ: Cardiac localization of eosinophil-granule major basic protein in acute necrotizing myocarditis. N Engl J Med 1990;323:1542-1545.
15. Tai P-C, Hayes DJ, Clark JB, Spry CJF: Toxic effects of human eosinophil products on isolated rat heart cells in vitro. Biochem J 1982;204:75-80.
16. Tai P-C, Spry CJF, Olsen EGJ, Ackerman SJ, Dunnette S, Gleich GJ: Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet 1987;1:643-647.
17. Parrillo JE, Borer JS, Henry WL, Wolff SM, Fauci AS: The cardiovascular manifestations of the hypereosinophilic syndrome: Prospective study of 26 patients, with review of the literature. Am J Med 1979;67:572-582.
18. Naito H, Nakatsuka M, Yuki K, Yamada H: Giant left ventricular thrombi in the hypereosinophlic syndrome: Report of two cases. J Cardiogr 1986;16:475-488.
19. Spry CJF, Take M, Tai P-C: Eosinophilic disorders affecting the myocardium and endocardium: A review. Heart Vessels 1985;1(suppl):240-242.
20. Take M, Sekiguchi M, Hiroc M, Hirosawa K, Mizoguchi H, Kijima M, Shirai T, Ishide T, Okubo S: Clinical spectrum and endomyocardial biopsy findings in eosinophilic heart disease. Heart Vessels 1985;1(suppl):243-249.
21. Gottdiener JS, Maron BJ, Schooley RT, Harley JB, Roberts WC, Fauci AS: Two-dimensional echocardiographic assessment of the idiopathic hypereosinophilic syndrome: Anatomic basis of mitral regurgitation and peripheral embolization. Circulation 1983;67:572-578.
22. Harley JB, Fauci AS, Gralnick HR: Noncardiovascular findings associated with heart disease in the idiopathic hypereosinophilic syndrome. Am J Cardiol 1983;52:321-324.
23. Gleich GJ, Loegering DA, Mann KG, Maldonado JE: Comparative properties of the Charcot-Leyden crystal protein and the major basic protein from human eosinophils. J Clin Invest 1976;57:633-640.